Keystone Financial Group acquired a new position in shares of Aurora Cannabis Inc (NYSE:ACB) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 16,829 shares of the company’s stock, valued at approximately $152,000.
Several other large investors also recently modified their holdings of the stock. Raymond James & Associates acquired a new stake in Aurora Cannabis in the 1st quarter valued at $486,000. Raymond James Financial Services Advisors Inc. acquired a new stake in Aurora Cannabis in the 1st quarter valued at $844,000. F3Logic LLC acquired a new stake in Aurora Cannabis in the 1st quarter valued at $141,000. CIBC Asset Management Inc increased its stake in Aurora Cannabis by 53.1% in the 1st quarter. CIBC Asset Management Inc now owns 832,620 shares of the company’s stock valued at $7,533,000 after buying an additional 288,939 shares during the last quarter. Finally, Oakworth Capital Inc. acquired a new stake in Aurora Cannabis in the 1st quarter valued at $35,000. Institutional investors and hedge funds own 8.35% of the company’s stock.
ACB has been the topic of several recent research reports. Jefferies Financial Group initiated coverage on shares of Aurora Cannabis in a research note on Monday, February 25th. They issued a “buy” rating on the stock. ValuEngine upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research note on Tuesday, March 19th. GMP Securities upgraded shares of Aurora Cannabis from a “hold” rating to a “buy” rating in a research note on Wednesday, March 13th. Desjardins initiated coverage on shares of Aurora Cannabis in a research note on Thursday, April 25th. They issued a “buy” rating and a $9.07 price target on the stock. Finally, Bank of America initiated coverage on shares of Aurora Cannabis in a research note on Wednesday, April 17th. They issued a “buy” rating and a $11.00 price target on the stock. One analyst has rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $9.86.
Aurora Cannabis (NYSE:ACB) last released its quarterly earnings data on Monday, February 11th. The company reported ($0.04) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.02. The company had revenue of $41.00 million for the quarter. Aurora Cannabis had a negative net margin of 122.65% and a positive return on equity of 1.32%. Research analysts expect that Aurora Cannabis Inc will post -0.18 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This report was originally posted by Week Herald and is the sole property of of Week Herald. If you are accessing this report on another domain, it was illegally copied and reposted in violation of US & international copyright & trademark law. The correct version of this report can be accessed at https://weekherald.com/2019/05/17/keystone-financial-group-invests-152000-in-aurora-cannabis-inc-acb.html.
Aurora Cannabis Profile
Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.
Featured Story: How do buyers and sellers choose a strike price?
Want to see what other hedge funds are holding ACB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aurora Cannabis Inc (NYSE:ACB).
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.